What is the clinical significance of an abnormal monocyte count in a 16-month-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

An abnormal monocyte count in a 16-month-old child is a significant indicator of underlying conditions that require medical attention, and the most recent study 1 suggests that monocyte anisocytosis corresponds with increasing severity of COVID-19 in children. The clinical significance of an abnormal monocyte count in a 16-month-old child depends on the degree of abnormality and associated symptoms.

  • Elevated monocytes (monocytosis) often suggest an ongoing infection, particularly bacterial infections like tuberculosis, certain viral infections, or recovery from acute infections.
  • It may also indicate inflammatory disorders, autoimmune conditions, or rarely, leukemia or other bone marrow disorders.
  • Conversely, decreased monocytes (monocytopenia) might suggest bone marrow suppression from medications, infections, or autoimmune conditions. A complete blood count with differential should be interpreted alongside the child's clinical presentation, including fever, irritability, or other signs of illness.
  • Additional testing may include blood cultures, inflammatory markers, or imaging studies based on symptoms.
  • Monitoring trends in monocyte counts over time is more valuable than a single reading. Parents should report any accompanying symptoms like persistent fever, lethargy, unusual bruising, or pallor.
  • While mild transient abnormalities may not require intervention, significant or persistent monocyte abnormalities warrant further investigation to identify and treat the underlying cause, as suggested by the study 1 which found that monocyte anisocytosis is a sensitive marker for severe pediatric COVID-19. The study 1 also found that an MDW threshold of 23 offers a sensitive marker for severe pediatric COVID-19, with improved accuracy when assessed in combination with other hematologic parameters.
  • This suggests that monocyte anisocytosis is a clinically accessible biomarker for severe COVID-19 in children. It is essential to consider the most recent and highest-quality study 1 when evaluating the clinical significance of an abnormal monocyte count in a 16-month-old child, as it provides the most up-to-date and reliable information on this topic.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.